Quantcast

Latest Cepheid Stories

2014-07-17 16:26:27

Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth SUNNYVALE, Calif., July 17, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenues for the second quarter of 2014 of $116.5 million, representing growth of 21% from $96.0 million for the second quarter of 2013. Net loss in the second quarter of 2014 was $(9.8) million, or $(0.14) per share, which compares to net loss of $(6.6) million, or $(0.10) per share, in the second quarter of 2013....

2014-07-03 12:26:25

SUNNYVALE, Calif., July 3, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 second quarter ended June 30, 2014 on Thursday, July 17, 2014, after the close of the market. The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, July 17, 2014, to discuss the results. To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled start...

2014-06-19 08:28:10

Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK SUNNYVALE, Calif., June 19, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced a new collaboration with AstraZeneca, Cubist Pharmaceuticals, Inc., and GSK intended to promote transformational change in infectious disease therapy by developing a rapid diagnostic test that can target multi-drug resistant pathogens and support the appropriate use of antibiotics. Targeting bacterial infections with the right...

2014-06-16 08:27:47

On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1 SUNNYVALE, Calif., June 16, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) Carba-R, an on-demand molecular test for rapid and accurate detection of carbapenemase-producing Gram-negative bacteria, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on...

2014-06-09 16:25:34

SUNNYVALE, Calif., June 9, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Peter Farrell to the position of Executive Vice President of International Commercial Operations. Philippe Jacon is transitioning to the role of President of HBDC, replacing Paul Steuperaert who will now focus on our business in sub-Saharan Africa, ahead of his retirement in 2015. These changes are effective today. "By the end of 2014, Cepheid expects to have 20 Xpert®...

2014-05-22 16:27:08

SUNNYVALE, Calif., May 22, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Jefferies Global Healthcare Conference, New York, NYMonday, June 2, 2014 at 11.00 a.m. Eastern Time William Blair Growth Stock Conference, Chicago, ILWednesday, June 11, 2014 at 8.00 a.m. Central Time Goldman Sachs Global Healthcare Conference, Rancho Palos Verdes, CAThursday,...

2014-04-29 20:27:04

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)http://www.reportbuyer.com/pharma_healthcare/healthcare/market_hospital_acquired_infection_control_sterilization_disinfection_testing_treatment.html Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the...

2014-04-29 16:31:46

SUNNYVALE, Calif., April 29, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. Baird Growth Stock Conference, Chicago, ILWednesday, May 7, 2014 at 11.30 a.m. Central Time Bank of America Merrill Lynch Health Care Conference, Las Vegas, NVWednesday, May 14, 2014 at 9.20 a.m. Pacific Time UBS Healthcare Conference, New York, NYWednesday, May 21, 2014 at...

2014-04-10 08:28:55

Accurate Norovirus Detection in as Short as One Hour SUNNYVALE, Calif., April 10, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert(®) Norovirus, a qualitative in vitro diagnostic test for rapid identification and differentiation of Noroviruses genogroup I (GI) and genogroup II (GII), to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert(®) System, the world's...

2014-04-03 16:24:14

SUNNYVALE, Calif., April 3, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2014 first quarter ended March 31, 2014 on Thursday, April 17, 2014, after the close of the market. The Company will host a management presentation at 2 p.m. Pacific Time on Thursday, April 17, 2014, to discuss the results. To access the live webcast, please visit Cepheid's website at http://ir.cepheid.com at least 15 minutes before the scheduled...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related